• Health in Tech received Nasdaq noncompliance notices October 12 and 14, 2026; neither immediately affects Class A common stock listing or trading.
• The closing bid price remained below $1 for 30 consecutive business days; compliance requires at least 10 consecutive business days at $1 or higher.
• The bid-price compliance deadline is April 12, 2027; a further 180-day extension depends on eligibility.
• Sanjay Shrestha’s August 10 resignation left the board without an independent majority and the audit committee below its three-member minimum.
• An independent director’s election November 10, 2026, followed by audit committee appointment, is expected to restore compliance before the February 8, 2027 deadline.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Health in Tech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-110269), on October 16, 2026, and is solely responsible for the information contained therein.